Company intelligence / Profile preview
ONK Therapeutics
Galway, County Galway, Irelandonktherapeutics.com ↗
- Ownership
- Private
- Employees
- ~35
- Development stage
- Preclinical
01
Overview
ONK’s lead candidate has demonstrated potent anti-tumor activity in preclinical models against multiple myeloma. The company’s pipeline includes several preclinical programs advancing toward IND-enabling studies and clinical trials. Their approach aims to maximize efficacy and reduce resistance by dual-targeting both intrinsic and extrinsic apoptotic pathways in cancer cells[3][4].
- Therapeutic areas
- OncologyHematology
- Modalities
- Natural killer (NK) cell therapieschimeric antigen receptor (CAR)-engineered NK cellsTRAIL variant-engineered NK cells
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
Request access →03
Partnerships
Intellia Therapeutics (CRISPR/Cas9 gene editing & LNP delivery technologies)WEHI – Walter and Eliza Hall Institute of Medical Research (CISH knockout technology)NAYA Biosciences for combination therapies with FLEX-NK™ bispecific antibodies[1][4]
Beyond the preview
Go deeper on ONK Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ONK Therapeutics.